Dom Centro de Reumatologia

CABA, Buenos Aires C1111AAJ

0 studies enrolling now · 5 studies all time

What they study most

Atopic Dermatitis, Colitis, Ulcerative, Crohn's Disease, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE)

Studies at this site

• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) — Completed
• A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) — Completed
• A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Stopped early
• A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis — Stopped early